MedTrace Logo

Lausanne Trialogue Paradigm - Brief: A Family Model for Child Mental Health in a Community Setting

NCT05356247 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2022-07-12

No results posted yet for this study

Summary

The current study is a feasibility pilot of the Lausanne Trialogue Play paradigm Intervention - Brief (LTP-Brief), a family systems therapy implemented in a community mental health setting. We will study the ultrabrief, virtual therapy to assess the feasibility of a future pilot RCT. Feasibility metrics include resource, scientific, and management considerations, as well as an examination of pre-post change in future child and family outcomes of interest.

Conditions

  • Parent-Child Relations
  • Family Relations
  • Internet-Based Intervention
  • Mental Health Issue
  • Behavioral Problem

Interventions

BEHAVIORAL

Lausanne Trialogue Play Brief

The brief treatment program will consist of an LTP family assessment with video feedback to caregivers to address family interaction patterns and child mental health. Families will participate in four sessions conducted online using the Zoom for Healthcare platform. In the first session, families will engage in a family assessment in different groupings that will be recoded on zoom and used later in the treatment. In the second session, taking place one week later, families will take part in a mini assessment to learn more about the difficulties of the child. In the third session, the clinical team will share videos of the family assessment to the parents and discuss the families strengths, concerns, and goals for moving forward. In the fourth session, taking place one month after the third session, families will participate in a check-in session, debriefing the family assessment.

Sponsors & Collaborators

  • University of Lausanne

    collaborator OTHER

  • SickKids Centre for Community Mental Health (SKCCMH)

    collaborator UNKNOWN

  • York University

    lead OTHER

Principal Investigators

  • Heather Prime, PhD · York University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
0 Months
Max Age
15 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-06-01
Primary Completion
2023-09-01
Completion
2023-09-01

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05356247 on ClinicalTrials.gov